Karen Wagner

Board Member at Aelix Therapeutics

Dr. Karen Wagner is a General Partner at Ysios Capital where she focuses on therapeutic investments. Dr. Wagner currently serves on the boards of AELIX Therapeutics, Vivet Therapeutics, Xeltis, and Minoryx Therapeutics.  Dr. Wagner holds a master’s degree in Molecular Biology and a Ph.D. in Cell Biology, both from the University of Konstanz, Germany.

Dr. Wagner has over 15 years of experience in business development and financing in the biotech/pharma sector working for companies such as F. Hoffmann-La Roche and GlycArt. Previously she was a Consultant in McKinsey & Company’s Global Healthcare Practice.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Aelix Therapeutics

Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection.


Headquarters

Barcelona, Spain

Employees

11-50

Links